The FDA has approved the NEXUS Aortic Arch Stent Graft enabling commercial launch of the NEXUS System in the US.

Designed to expand treatment options for patients with cirrhosis and complications of portal hypertension, this ...

Ureteral stents are widely used to relieve obstruction and protect kidney function, but they can also become blocked, ...

BDX seeks CE Mark for its Liverty TIPS Stent Graft, a next-gen device aimed at improving portal hypertension treatment and ...

When a ureteral stent fails, pressure can quietly build inside the kidney long before clinical symptoms. A new device called ...

According to MarketsandMarkets™, the Gastrointestinal Stent Market is projected to grow from about USD 0.62 billion in 2026 ...

BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced application of ...

The authors say that the paper is correct and that the stents are made by Abbott, and that the registry is inaccurate. An ...

Endospan, a privately-held company pioneering solutions for the endovascular repair of aortic arch disease, today announced that the U.S. Food and Drug Administration (FDA) has approved the NEXUS (R) ...

Endospan, an Israel-based developer of solutions for the endovascular repair of aortic arch disease, announced that the FDA ...

Getinge announced it has received FDA premarket approval for additional sizes of its iCast covered stent system. The approval ...

This technology reduces complications and pain for our patients and is a real step forward for patient centered care.” — Professor Sascha Pahernik MD BAIERSDORF, BAVARIA, GERMANY, March 25, 2026 ...